Myeloid cell-targeted nanocarriers efficiently inhibit cellular inhibitor of apoptosis for cancer immunotherapy
Published inCell chemical biology, vol. 27, no. 1, p. 94-104.e5
Publication date2020-01-16
First online date2020-01-02
Abstract
Keywords
- Cancer
- Dendritic cells
- Drug delivery
- High-content drug screening
- Immunotherapy
- Interleukin-12
- Nanoparticle
- Alkynes / chemistry
- Alkynes / pharmacology
- Animals
- Antineoplastic Agents / chemistry
- Antineoplastic Agents / pharmacology
- Apoptosis / drug effects
- Cell Line, Tumor
- Colonic Neoplasms / metabolism
- Colonic Neoplasms / pathology
- Colonic Neoplasms / therapy
- Dendritic Cells
- Drug Carriers / chemistry
- Drug Evaluation, Preclinical
- Interleukin-12 / biosynthesis
- Mice
- Myeloid Cells / drug effects
- Myeloid Cells / metabolism
- Myeloid Cells / pathology
- Nanoparticles / chemistry
- Oligopeptides / chemistry
- Oligopeptides / pharmacology
- Small Molecule Libraries / chemistry
- Small Molecule Libraries / pharmacology
- Thiazoles / chemistry
- Thiazoles / pharmacology
Affiliation Not a UNIGE publication
Citation (ISO format)
KOCH, Peter D et al. Myeloid cell-targeted nanocarriers efficiently inhibit cellular inhibitor of apoptosis for cancer immunotherapy. In: Cell chemical biology, 2020, vol. 27, n° 1, p. 94–104.e5. doi: 10.1016/j.chembiol.2019.12.007
Main files (2)
Article (Accepted version)
![accessLevelPublic](assets/images/access-level-free.png)
Article (Published version)
![accessLevelPublic](assets/images/access-level-free.png)
Identifiers
- PID : unige:169001
- DOI : 10.1016/j.chembiol.2019.12.007
- PMID : 31902676
- PMCID : PMC7422681
ISSN of the journal2451-9448